Artera has secured CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI prostate ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection ...

A digital rectal exam (DRE) is a way to check for signs of prostate cancer. For this exam a physician inserts a gloved, lubricated finger into your rectum to: Feel your prostate gland Assess the ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Learn about prostate cancer risks, warning signs, and the importance of PSA testing for early detection and treatment.

The stigma around getting tested for prostate cancer is not great. Many men avoid getting tested for this reason, which is ...

The at-home tests are in line with Labour’s 10-year health plan for more patients to directly access diagnostic services. The ...

Simeon Greene, from Wolverhampton, believes 54 of his relatives may have had prostate cancer.

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis – the detection of a cancer that would never have been diagnosed during a patient’s ...